3Cvitkovic E. Ongoing and unsaid on oxaliplatin: the hope [J]. Br J Cancer,1998 ,77 ( Suppl 4) :8.
4Nagy B, Molnar J, Rovo L, et al. Effective chemoradiotherapy without additive toxicity in locoregionally advanced head and neck cancer[J]. Anticancer Res,2003,23 (5b):4 329.
4Desoize B, Madotdet C. Particular aspects of platinum conrpounds used at present in cancer treatment. Crit Rev Oncol Hematol, 2002, 42 : 317-325.
5Inaba H, Tsuda T, Miyazaki A, et al. Clinical study of the combination of small amount of nedaplatin ( NDGP)/5-FU with radiation for the treatment of esophageal cancer. Nippon Shokakibyo Gakkai Zasshi, 2002, 99 : 1191-1196.
6Fujii M, Tokumaru Y, Imanishi Y, et al. Combination chemotherapy with nedaplatin and 5-FU for head and neck cancer. Gan To Kagaku Ryoho, 1998, 25:53-58.
7Kato H, Fukuchi M, Manda R, et al. Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas. Anticancer Res, 2003, 23:3493-3498.
4Jonathan C, Jonas T. Quality of life, functional outcome and cost of early glottis cancer[ J]. Laryngoscope ,2003 ; 113 ( 1 ) :67-76.
5WHO. The development of the WHO quality of life assessment instru- ment. Geneva, WHO, 1993.
6Wong R, Malthaner R. Combined chemotherapy and radiotherapy (withoutsurgery) compared with radiotherapy alone in localized carcinoma of the esophagus[J].Cochrane Database Syet Rev, 2006,25( 1 ): 2092.
7Kato K,Muro K,Minashi K, et al. Phase Ⅱ study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage Ⅱ - Ⅲ esophageal squamous cell carcinoma: JCOG trial (JCOG 9906) [J].lnt J Radiat Oncol Biol Phys,2011,81(3): 684-690.
8Yamamoto S,Ishihara R,Motoori M,et al. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophagear squamous cell carcinoma [J]. Am J Gastroenterol,2011, 106(6): 1048-1054.
9Tougeron D,Di Fiore F,Thureau S,et al. Safety and outcome of definitive chemoradiotherapy in elderly patients with oe- sophageal cancer[J].Br J Cancer,2008,99(10): 1586-1592.
10Mauer A M,Kraut E H,Krauss S A,et al. Phase Ⅱ trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus[J].Ann Oncol,2005,16(8): 1320-1325.
